Walleye Trading’s Sinovac Biotech SVA Stock Holding History
Bought
Maintained
Sold
Other funds holding SVA
NAH
Walleye Trading's SVA Position: Q4 2017 in Review
Walleye Trading sold out of Sinovac Biotech (SVA) in Q4 2017, closing a stake of 49,065 shares — an estimated $346K sold.
Walleye Trading first reported a position in SVA in Q2 2015 and held it in 7 quarters. The position peaked at $346K in Q3 2017. 31 funds tracked by Wall St. Rank hold SVA as of Q4 2017.
- Walleye Trading reported no remaining Sinovac Biotech position as of Q4 2017 after selling out during the quarter.
- Walleye Trading sold 49,065 Sinovac Biotech shares in Q4 2017, an estimated $346K.
- Walleye Trading first reported a position in Sinovac Biotech in Q2 2015 and held it in 7 quarters.
- Walleye Trading's Sinovac Biotech position peaked at $346K in Q3 2017.
- 31 funds tracked by Wall St. Rank held Sinovac Biotech as of Q4 2017.
Based on Walleye Trading's 13F filing for Q4 2017, filed 14 Feb 2018.